Ascentawits
Latest round
- Series A
Last raised
- Feb 2020
Total raised
- Undisclosed
Investors
- 6
About Ascentawits
Based in Shenzhen, China, and established in 2014, Ascentawits is a biotechnology company that focuses on the development of tumor drugs. It has established partnerships with Shenzhen University, OBI Pharma, Shenzhen Bay Laboratory, etc. In June 2023, AST-006 was acquired the NMPA implied permission to enter clinical trials. The chairman of the board and general manager, Jianxin Duan graduated from the University of Florida. The company specializes in developing small molecule targeted coupling drugs such as AST-3424, AST-001, AST-006, and so on, which entered the industrialization stage. It has developed a targeted small molecule coupled drug platform based on AKR1C3 enzyme activation and a targeted small molecule coupled drug platform based on hypoxia activation. The company generates revenue by providing small molecule targeted coupling drugs.
Who invested in Ascentawits
6 investors across 2 rounds
See all investors in Ascentawits
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ascentawits
Who invested in Ascentawits?
Ascentawits has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ascentawits raised?
Ascentawits has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ascentawits last raise money?
Ascentawits's most recent round on record is a Series A, in Feb 2020.
What does Ascentawits do?
Based in Shenzhen, China, and established in 2014, Ascentawits is a biotechnology company that focuses on the development of tumor drugs.
Where is Ascentawits headquartered?
Ascentawits is headquartered in Shenzhen, China.
Which VCs invest in companies like Ascentawits?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Ascentawits's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series A
Raising like Ascentawits? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.